NeuroSoV
PrivateLast Round
Grant
Nov 20, 2025
Total Funding Raised
$80,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NeuroSoV operates in Healthcare & Life Sciences and is based in Covilhã. Its latest recorded funding round was a Grant round in November 2025.
NeuroSoV is a biotechnology company focused on the discovery and development of cutting-edge therapies targeted at slowing down neurological disorders, with an initial focus on Parkinson's Disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroSoV Comparables
Compare NeuroSoV with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Muna Therapeutics | 80% | |
| Lario Therapeutics | 79% | |
| Neuron23 | 78% |
For institutional investors. Book with your work email.
NeuroSoV Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuroSoV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Building Global Innovators | Accelerator |
| Women TechEU | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2026
Grew 100% QoQ from 3 to 6 employees.
- Jan 23, 2026
Monthly visitors increased 51% MoM.
For institutional investors. Book with your work email.
NeuroSoV Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroSoV's valuation, stock price, and market status.
Is NeuroSoV a public or private company?
NeuroSoV is a private company.
What is the current stock price of NeuroSoV?
NeuroSoV is a private company, so its shares have no public market price. Caplight tracks NeuroSoV's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroSoV worth (valuation)?
Valuation information for NeuroSoV is not publicly available.
Can I buy NeuroSoV stock?
NeuroSoV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroSoV's last funding round?
NeuroSoV's most recent funding round was Grant on November 20, 2025.
Who are the main investors in NeuroSoV?
Key investors in NeuroSoV include Building Global Innovators, Women TechEU.
Will NeuroSoV IPO soon?
No public IPO plans have been announced for NeuroSoV.
How can I track NeuroSoV secondary market activity?
Caplight tracks bids, offers, and trades in NeuroSoV's shares on secondary markets.